Top 10 Key Players companies in Urothelium by Highest Patent Value in the United States in 2019 – Discovery

Free Trial

The Urothelium top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Urothelium Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	TARIS BioMedical LLC	Massachusetts, United States	Medicine,Health care,Pharmacy and Therapeutics, ...[+2]	Avg patent value: 2.18 M
2	Hitachi Chemical Co. America Ltd.	California, United States	Semiconductor,Electronic component	Avg patent value: 270,000
3	TesoRx Pharma LLC	California, United States	Urology,Medicine,Health care, ...[+2]	Avg patent value: 137,000
4	Genentech, Inc.	California, United States	Biotechnology,Biology,Medicine, ...[+2]	Avg patent value: 110,000
5	Urigen Pharmaceuticals, Inc.	Delaware, United States	Interstitial cystitis,Medicine,Health care, ...[+2]	Avg patent value: 90,000
6	Affinergy LLC	North Carolina, United States	Bone cement,Knee replacement,Medical equipment, ...[+2]	Avg patent value: 68,000
7	LIPAC Oncology LLC	California, United States	Oncology,Carcinoma,Bladder cancer, ...[+1]	Avg patent value: 38,000
8	Revance Therapeutics, Inc.	California, United States	Botulinum toxin,Medicine,Health care, ...[+2]	Avg patent value: 17,000
9	Exelixis, Inc.	California, United States	Oncology drugs,Health care,Drug, ...[+2]	Avg patent value: 3,300
10	DUSA Pharmaceuticals, Inc.	Massachusetts, United States	Medicine,Levulan,Photodynamic therapy, ...[+2]	Avg patent value: 0